Rituximab in Combination with Cyclophosphamide, Vincristine, Doxorubicin and Prednisone for Treatment of Initially Diagnosed Diffuse Large B Cell Lymphoma: A multi-center Clinical Study
Lists
Only you see this
Abstract
AIM: To evaluate the efficacy of rituximab combined with cyclophosphamide, yincristine, doxorubicin, and prednisone (CHOP) in treating the initially diagnosed diffuse large B cell lymphoma (DLBL). METHODS: From Apr. 2002 to Feb. 2003, 52 patients were enrolled in this study. Chemotherapy was conducted with cyclophosphamide 600mg•m^(-2), vincristine 1.4mg•m^(-2), doorubicin 25mg•m^(-2) on d 1 and prednisone 60mg•m^(-1) for successive 5d (standard CHOP). There were 6 courses, 3 wk each. Rituximab 375mg•m^(-2) was infused once a week, 2 d before the first course of chemotherapy (successive infusion) for 4 times on standard dose or for 6 times on extended dose. Or rituximab was infused once every 3 wk, 2 d before each CHOP (separated infusion) for 4 times on the schedule of standard dose or for 6 times on the extended dose. RESULTS: The complete response (CR) rate (60%) and total effective (100%) were achieved in 50 patients who were evaluated for efficacy, respectively. And among 34 patients in Ann Arbor stage Ⅲ and Ⅳ, 15 patients were completely relieved. The complete effective rate was 44%. Fifty patients were followed-up for (8±s 5) wk, 2-30 wk and estimated progress free survival (PFS) rate of 16 wk was 87 %. Standard and extend regimen were not different in effect, as well as the separated or concentrated infusion of rituximab (P>0.05). The regimen could be well tolerated, and the major adverse reactions were infusion-related response (32%) and hematological toxicities (20%). CONCLUSION: Rituximab in combined with CHOP can be successfully applied to the therapy of initially diagnosed diffuse large B cell lymphoma, with high CR rate and mild adverse reactions.
BibTeX
@inproceedings{li2004rituximab,
author = {Junmin Li and Yang Shen and Fangyuan Chen and Yi Xie and Chun Wang and Jian Hou and Xiaonan Hong and Depei Wu and Jia Chen and Ming Hou and Jianmin Xu and Zhixiang Shen},
title = {{Rituximab in Combination with Cyclophosphamide, Vincristine, Doxorubicin and Prednisone for Treatment of Initially Diagnosed Diffuse Large B Cell Lymphoma: A multi-center Clinical Study}},
booktitle = {Chinese},
year = {2004},
}Loading related content...